Treatment for shoulder pain after stroke using radiofrequency ablation
Efficacy of Suprascapular Radiofrequency Ablation Versus USG-guided Suprascapular Nerve Blockade and Intra-articular Steroid Injections in Hemiplegic Shoulder Pain: A Three-blind Randomized Controlled Study.
This study is testing whether a special treatment called radiofrequency ablation can help people with shoulder pain after having a stroke feel better compared to other common treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 84 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ankara Etlik City Hospital Government |
| Locations | 1 site (Ankara, Yenimahalle) |
| Trial ID | NCT06473389 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of suprascapular radiofrequency ablation for patients suffering from hemiplegic shoulder pain following a stroke. It is a prospective, triple-blind randomized controlled study involving patients diagnosed with hemorrhagic or ischemic stroke at least three months prior. Participants will be randomly assigned to one of three groups: radiofrequency ablation, suprascapular nerve block, or intra-articular steroid injection. The study aims to assess pain relief using a visual analog scale (VAS) and will include a total of 84 patients to ensure statistical significance.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who have experienced a stroke at least three months prior and have moderate to severe shoulder pain.
Not a fit: Patients with a history of shoulder pain prior to the stroke or those who have undergone recent interventional procedures for shoulder pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce shoulder pain in stroke survivors, improving their quality of life and rehabilitation outcomes.
How similar studies have performed: Previous studies have shown promise in using nerve blocks for post-stroke shoulder pain, but the specific application of radiofrequency ablation is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Being over 18 years old 2. Those who were diagnosed with hemorrhagic or ischemic stroke at least 3 months ago 3. Patients with shoulder pain with VAS \> 5 severity after hemiplegia 4. Those who agree to participate with a consent document (their own or their foster family) Exclusion Criteria: 1. Those who did not provide a consent document 2. Those under 18 years of age 3. Those who cannot cooperate 4. Severely aphasic patients 5. Patients with shoulder pain VAS \>5 severity 6. Patients who have undergone interventional procedures such as RF, suprascapular nerve blockade, steroid injection, etc. for the shoulder area in the last 3 months 7. Patients with bleeding diathesis 8. Those with a history of surgery or radiotherapy in the shoulder area 9. Those who had shoulder complaints before the stroke 10. Patients with pacemakers 11. Patients with MMT Score \<24
Where this trial is running
Ankara, Yenimahalle
- Etlik City Hospital — Ankara, Yenimahalle, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: YUNUS BURAK BAYIR, specialist
- Email: yunusburakbayir@gmail.com
- Phone: 05058083317
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.